Tendencias de diagnóstico y tratamiento del dolor neuropático en México
Por:
Guevara-López U., Covarrubias-Gómez A., Hernández-Jiménez S., Palapa-García R., Acosta-Alanís F.D.J., Aragón G., Amescua C., Carrasco-Rojas A., Carrillo-Esper R., Cervantes P., Collado-Corona M.A., Coyado G., De Font-Reáulx R E., De Lille Fuentes R., García-Ramos G., Guajardo-Rosas J., Hernández-Santos R., Martínez Á., Ochoa-Carrillo F., Pérez-Lascas E.L., Plancarte-Sánchez R., Robles-Elías J., Velásquez-Ramos J., Rodríguez-Cabrera R., Tenopala-Villegas S.
Publicada:
1 ene 2006
Resumen:
Background: Neuropathic pain is difficult to define. It is associated to various conditions and injuries to the nervous system, with signs and symptoms that may or may not be related to the injured site, which makes its diagnosis more difficult. Objective: To identify the trends in diagnosis and treatment of neuropathic pain among Mexican physicians. Method: A questionnaire was submitted to a sample of 105 Mexican physicians from different specialties, living in several states across the country. Results: Out of the respondents, 61% reported treating patients with neuropathic pain, and 17% considered this the most common type of pain in their practice. Allodynia was reported as the predominant clinical feature (50%), followed by hyperesthesia (12.8%) and hyperalgesia (8.6%). As a «first line» drug treatment, 57.1% preferred anticonvulsants; 32.8%, antidepressants; 20%, NSAIDs; 18.5% weak opioids; and 5.7%, stronger opioids (the answer could include more than one type of drugs). Conclusions: Neuropathic pain is a common condition, often difficult to diagnose and to treat. Therefore, the availability of general practice guidelines for a correct clinical diagnosis and treatment would greatly improve its management.
|